Jian-Ri Li

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Prostate Cancer

Benign Prostatic Hyperplasia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

BioFactors (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu, Sheng-Chun Hung, Jun-Peng Chen, Jian-Ri Li
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PloS one 18 (3) (2023)
Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu, Sheng-Chun Hung, Jun-Peng Chen, Jian-Ri Li
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PloS one 18 (3) (2023)
Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu, Sheng-Chun Hung, Jun-Peng Chen, Jian-Ri Li
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PloS one 18 (3) (2023)
Chen-Hsun Hsueh, Li-Wen Chang, Kun-Yuan Chiu, Sheng-Chun Hung, Jun-Peng Chen, Jian-Ri Li
Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PloS one 18 (3) (2023)
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, Tu Van Dao, Daniel Castellano, Jian-Ri Li, Som D Mukherjee, Kathryn Howells, Hannah Dry, Mark C Lanasa, Ross Stewart, Dean F Bajorin
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, Hiroyuki Nishiyama, Andrea Necchi, Howard Gurney, Jae Lyun Lee, Michiel S Van Der Heijden, Eli Rosenbaum, Nicolas Penel, See-Tong Pang, Jian-Ri Li, Xavier García Del Muro Solans, Florence Joly Lobbedez, Zsuzsanna Pápai, Weichao Bao, Peter Ellinghaus, Chengxing Lu, Mitchell Sierecki, Sabine Coppieters, Keiko Nakajima, Tatiane Cristine Ishida, David I Quinn
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1 / 3 mRNA Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, Chen-Li Cheng, Sheng-Chun Hung, Ching-Heng Lin, Kun-Yuan Chiu
Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study. PloS one 17 (6) (2022)
Jian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou, Shian-Shiang Wang, Chuan-Su Chen, Cheng-Kuang Yang, Hao-Chung Ho, Chen-Li Cheng, Chi-Rei Yang, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen Lin, Sheng-Chun Hung, Chiann-Yi Hsu, Chun-Jung Chen
Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma. BioFactors (Oxford, England) 45 (1) (2018)